We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, Sony, American Express and Southern Company
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 1, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc. (GOOGL - Free Report) , Eli Lilly and Co. (LLY - Free Report) , Sony Group Corporation (SONY - Free Report) , American Express Company (AXP - Free Report) and The Southern Company (SO - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for Alphabet, Eli Lilly and Sony
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet, Eli Lilly, and Sony. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Alphabet have outperformed the S&P 500 over the past year (+81.5% vs. +44%), with the better-than-expected Q3 results adding to the stock's momentum. The Zacks analyst believes that its focus on innovation, strategic acquisitions and Android OS will continue to generate strong cash flow.
A robust cloud division and expanding data centers continue to strengthen its presence in the cloud space. The company also continues to benefit from major updates in its search segment to enhance search results. Alphabet’s efforts to improve AI techniques and its focus on the home automation space should is expected to aid business growth in the long term.
Eli Lilly shares have gained +52.6% in the year to date period against the Zacks Large Cap Pharmaceuticals industry’s gain of +16.5%. The Zacks analyst believes that Lilly has been benefiting significantly higher demand for drugs like Trulicity, Taltz, and others. An intriguing pipeline for cancer, diabetes and Alzheimer's drugs is another tailwind.
The company recently submitted regulatory applications for tirzepatide and donanemab to be used in treatments for type II diabetes and early Alzheimer's disease, respectively. Both these candidates possess sales potential worth billions of dollars. Generic competition for several drugs, pricing pressure in the United States, and price cuts in certain international markets including China, Japan and Europe remain as major headwinds though.
Shares of Sony have gained +14.9% over the past six months against the Zacks Audio Video Production industry’s gain of +13.3%. The Zacks analyst believes that its Electronics Products & Solutions segment has been benefiting from an increase in sales of televisions and digital cameras.
Sony raised its outlook for the fiscal year ending Mar 31, 2022. The company has been witnessing a surge in Game & Network Services, Pictures, Music, and Electronics Products & Solutions segments sales. The continued increase in cost of goods sold is a major concern for the company though. It has a strong international presence with a chunk of its revenues stemming from emerging markets; this makes its susceptible to fluctuations in foreign currency exchange rates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, Sony, American Express and Southern Company
For Immediate Release
Chicago, IL – November 1, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alphabet Inc. (GOOGL - Free Report) , Eli Lilly and Co. (LLY - Free Report) , Sony Group Corporation (SONY - Free Report) , American Express Company (AXP - Free Report) and The Southern Company (SO - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for Alphabet, Eli Lilly and Sony
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet, Eli Lilly, and Sony. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Alphabet have outperformed the S&P 500 over the past year (+81.5% vs. +44%), with the better-than-expected Q3 results adding to the stock's momentum. The Zacks analyst believes that its focus on innovation, strategic acquisitions and Android OS will continue to generate strong cash flow.
A robust cloud division and expanding data centers continue to strengthen its presence in the cloud space. The company also continues to benefit from major updates in its search segment to enhance search results. Alphabet’s efforts to improve AI techniques and its focus on the home automation space should is expected to aid business growth in the long term.
(You can read the full research report on Alphabet here >>>)
Eli Lilly shares have gained +52.6% in the year to date period against the Zacks Large Cap Pharmaceuticals industry’s gain of +16.5%. The Zacks analyst believes that Lilly has been benefiting significantly higher demand for drugs like Trulicity, Taltz, and others. An intriguing pipeline for cancer, diabetes and Alzheimer's drugs is another tailwind.
The company recently submitted regulatory applications for tirzepatide and donanemab to be used in treatments for type II diabetes and early Alzheimer's disease, respectively. Both these candidates possess sales potential worth billions of dollars. Generic competition for several drugs, pricing pressure in the United States, and price cuts in certain international markets including China, Japan and Europe remain as major headwinds though.
(You can read the full research report on Eli Lilly here >>>)
Shares of Sony have gained +14.9% over the past six months against the Zacks Audio Video Production industry’s gain of +13.3%. The Zacks analyst believes that its Electronics Products & Solutions segment has been benefiting from an increase in sales of televisions and digital cameras.
Sony raised its outlook for the fiscal year ending Mar 31, 2022. The company has been witnessing a surge in Game & Network Services, Pictures, Music, and Electronics Products & Solutions segments sales. The continued increase in cost of goods sold is a major concern for the company though. It has a strong international presence with a chunk of its revenues stemming from emerging markets; this makes its susceptible to fluctuations in foreign currency exchange rates.
(You can read the full research report on Sony here >>>)
Other noteworthy reports we are featuring today include American Express and Southern Company.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.